Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, June 17, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

NEW ORLEANS - In a federal class action, a woman claims she suffered two heart attacks from taking Xanodyne Pharmaceuticals' drug Darvocet (propoxyphene), which did not even kill pain as it was supposed to, and which Xanodyne knew had been "subject to safety concerns for decades."

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.